TheEdgeResearch
Home / Stocks / GBHPF

Global Hemp Group Inc. (GBHPF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$2,429
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.05
52-Wk Range
0.0001-0.58055
CEO
Curtis Ralph William Huber
Country
CA
Currency
USD

Global Hemp Group Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in North Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,429. On trailing twelve-month figures it carries a trailing P/E of -0.13, a net margin of 0.0%. Its beta of 1.05 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.13
Price / Sales
0.00
Price / Book
-0.06
EV / EBITDA
-162.87
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.62
Current ratio
0.04
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
18
IPO date
2014-04-22
Headquarters
North Vancouver, BC, CA
About Global Hemp Group Inc.

Global Hemp Group Inc. is an enterprise focused on the cultivation and processing of industrial hemp within the United States. Its primary objective is to create sustainable, eco-friendly, and value-added products by comprehensively utilizing the hemp plant for diverse commercial applications. Established in 2009, the company initially operated under the name Arris Holdings Inc. before officially rebranding as Global Hemp Group Inc. in March 2014. The company maintains its corporate headquarters in North Vancouver, Canada.

Comparable companies

Global Hemp Group Inc. is most often compared with the following Healthcare names:

CNNXFCSTFGRVEHMPQINSOLTHOLVTTFMGWFFTMSHVIVXF
More research on GBHPF
GBHPF technical analysis GBHPF TheEdge Score Compare against peers
Open full interactive analysis & DCF →